Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Professional Topics

Subcategories:Career DevelopmentInterprofessional PerspectivePresident's PerspectiveProfilesRheuminations

ARHP Launches Updated Fundamentals of Rheumatology Course

Gretchen Henkel  |  March 17, 2018

The ARHP is pleased to announce the relaunch of its highly successful online Fundamentals of Rheumatology Course (FRC). This updated version is earning high marks from users and reviewers for ease of navigation, choice of presentation formats, depth of research and separate learning activities (i.e., modules) for the care of adult and pediatric patients. According…

Volunteer Roles in the ACR to Match Your Interest

David I. Daikh, MD, PhD, & Mark Hwang, MD  |  March 17, 2018

Rheumatology is a small specialty, but the ACR has a large footprint in terms of activities and impact. The ACR’s remarkable success can be attributed to effective col­laboration between a highly professional and talented staff and a large number of volunteer members. Under the direction of the Board of Directors, the activities and strategic initiatives…

The Battle with Insurance Companies to Obtain Prescriptions

Philip Seo, MD, MHS  |  March 17, 2018

If you are a news junkie, then you know that a tick-tock is a story that relies heavily on chronology, counting down the events of the day, in order, as inexorably as the ticking clock. These types of timeline stories have become very popular in the fast-paced world of modern politics, in which readers eat…

ACR Members Begin Work on CMS Committees

Carol Patton  |  March 16, 2018

TEP In February, Lisa Gale Suter, MD, joined the Technical Expert Panel (TEP) for the Centers for Medicare & Medicaid Services (CMS) Quality Measure Development Plan, supporting the transition to the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs). She was nominated to serve in this role by the ACR. The panel comprises…

Invest in RheumPAC Now to Support the Future of Rheumatology

Ryan Jessee, MD  |  March 15, 2018

If there’s one thing America needs right now, it’s more money in politics. I’m being facetious, but I do want to ask all of you to invest in RheumPAC today. Given the relatively small size of our subspecialty, it is easy for lawmakers to overlook the consequences that laws may have on our field of…

Connect Rheumatology: A Conversation with Paul Sufka, MD, ACR Committee on Marketing & Communications Member

Carina Stanton  |  March 15, 2018

The field of rheumatology is advancing fast—alongside communication technologies that generate a massive amount of information. Paul Sufka, MD, a rheumatologist with HealthPartners in St. Paul, Minn., is interested in the ways social media can help him and other rheumatologists stay connected and keep abreast of practice information. “One thing I see people doing too…

U.S. Health Spending Is Twice Other Countries’, with Worse Results

Lisa Rapaport  |  March 15, 2018

(Reuters Health)—The U.S. spends about twice what other high-income nations do on healthcare, but has the lowest life expectancy and the highest infant mortality rates, a new study suggests. More doctor visits and hospital stays aren’t the problem. Americans use roughly the same amount of health services as people in other affluent nations, the study…

2018 FNIH Trailblazer Prize for Clinician-Scientists Nomination Deadline: March 30

Foundation for the National Institutes of Health  |  March 12, 2018

In 2018, the Foundation for the National Institutes of Health (FNIH) will present the FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), which recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care. This $10,000 honorarium and prize celebrates the achievements of medical doctors…

Health Insurer Cigna to Buy Express Scripts for about $54 Billion

Ankur Banerjee  |  March 8, 2018

(Reuters)— U.S. health insurer Cigna Corp said on Thursday it would buy pharmacy benefits manager Express Scripts Holding Co for about $54 billion, a tie-up that reflects pressure on healthcare companies to grow bigger to cut costs. The move follows the $69-billion merger of insurer Aetna Inc and one of Express Scripts’ biggest rivals, CVS…

FDA’s Gottlieb Blames Industry ‘Kabuki Drug Pricing’ for High Costs

Yasmeen Abutaleb  |  March 8, 2018

WASHINGTON (Reuters)—U.S. Food and Drug Administration chief, Scott Gottlieb, criticized pharmacy benefit managers, health insurers and drugmakers on Wednesday for “Kabuki drug-pricing constructs” that profit the industry at the expense of consumers. The comments, made at a conference organized by a leading U.S. health insurer lobbying group, stoked speculation over what steps the administration of…

  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 228
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences